Metraipolis › archive › dc_e64dcec8322f

Comparative Outcomes of Apixaban and Acenocoumarol in Advanced Chronic Kidney Disease and Atrial Fibrillation: A Retrospective Observational Study — Europe PMC PMID:41464761

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41464761
DOI
10.3390/jcm14248860
License (as archived)
solo-consultazione
Archived
2026-11-07T15:39:26.199Z
SHA-256 of the archived text
88a1684ea014e18b76f3d4de246754fbfd9bc735beaf2d902664f102baf68fc1
Stable URL of this page
https://metraipolis.com/documento/dc_e64dcec8322f

How to cite

Comparative Outcomes of Apixaban and Acenocoumarol in Advanced Chronic Kidney Disease and Atrial Fibrillation: A Retrospective Observational Study — Europe PMC PMID:41464761 — Europe PMC (en), https://europepmc.org/article/MED/41464761 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e64dcec8322f (Metraipolis archive dc_e64dcec8322f, sha256 88a1684ea014e18b76f3d4de246754fbfd9bc735beaf2d902664f102baf68fc1)
BibTeX
@misc{dce64dcec8322f,
  title = {Comparative Outcomes of Apixaban and Acenocoumarol in Advanced Chronic Kidney Disease and Atrial Fibrillation: A Retrospective Observational Study — Europe PMC PMID:41464761},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41464761},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e64dcec8322f; sha256 88a1684ea014e18b76f3d4de246754fbfd9bc735beaf2d902664f102baf68fc1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41464761. Agents can read the archived copy with the MCP tool read_document.